Evidence map›Paper›PMID 40407816›Full record

ArticleEmerging microbes & infections2025

Respiratory transmission potential of severe fever with thrombocytopenia syndrome bunyavirus: evidence from intranasal exposure in a humanized mouse model.

Dafeng Lu, Yifang Han, Ruowei Xu, Chunfang Wang, Mingke Qin, Jianwei Shi, Fuqiang Ye, Jinhai Zhang, Zhenghan Luo, Yuhe Wang and 4 more

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dafeng LuSchool of Public Health, Capital Medical University, Beijing, People's Republic of China.
Yifang HanDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Ruowei XuDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Chunfang WangDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Mingke QinDepartment of Occupational Health, Third Military Medical University, Chongqing, People's Republic of China.
Jianwei ShiDepartment of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, People's Republic of China.
Fuqiang YeDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Jinhai ZhangDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Zhenghan LuoDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Yuhe WangDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Hong LinDepartment of Blood Research Center, Jiangsu Province Blood Center, Nanjing, People's Republic of China.
Peiqi JiaDepartment of Clinical Laboratory, General Hospital of Eastern Theater Command, Nanjing, People's Republic of China.
Jin ZhuDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.
Chunhui WangDepartment of infectious Disease Prevention and Control, Nanjing Bioengineering (Gene) Technology Centre for Medicine, Nanjing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe Fever with Thrombocytopenia Syndrome Bunyavirus (SFTSV) is a highly lethal pathogen with expanding endemic regions in Asia. While primarily transmitted by ticks, recent evidence suggests potential airborne transmission, raising significant public health concerns. This study investigates the potential for respiratory transmission and pathogenesis using humanized NCG mice inoculated with SFTSV via subcutaneous injection challenge (SIC) or intranasal drop challenge (IDC). Both groups demonstrated rapid systemic dissemination, marked by viremia, weight loss, and multi-organ injury, with hemorrhagic manifestations observed in high-dose infection groups. Histopathological evaluations revealed lung pathology in the intranasal drop challenge mice, including extensive alveolar disruption and inflammatory cell infiltration. Transcriptomic analyses further confirmed that respiratory route inoculation resulted in heightened expression of inflammatory signalling pathways such as IL-17 and NF-κB, potentially contributing to severe local immunopathology. Subcutaneous infection provoked an earlier systemic immune response, with significant upregulation of antigen-processing genes in peripheral blood mononuclear cells. Nevertheless, both routes ultimately culminated in widespread injury to the liver, spleen, kidney, highlighting the systemic nature of SFTSV pathogenesis. These findings underscore the need for preventive strategies addressing respiratory spread.

Indexed as

PhlebovirusSevere Fever with Thrombocytopenia SyndromeAdministration, IntranasalAnimalsDisease Models, AnimalFemaleHumansLungMicehumanized mouse modelintranasal drop challengenext-generation sequencingrespiratory transmission potentialSFTSV

Identifiers

PMID40407816
PMCPMC12180321

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.